Subcortical ischemic depression

Last updated

Subcortical ischemic depression, also known as vascular depression, is a medical condition most commonly seen in older people with major depressive disorder. Subcortical ischemic depression refers to vascular depression specifically due to lesions and restricted blood flow, known as ischemia, in certain parts of the brain. However, the disorder is typically described as vascular depression in the literature.

Contents

There is no formal and accepted definition of vascular depression and the hypothesis requires further research to support the causal link between these vascular lesions and depression. [1] Thus, it is difficult to determine if vascular depression can be considered a distinct sub-type of major depressive disorder (MDD). However, with current criteria, some studies estimate that vascular depression may account for over half of the cases of MDD in the elderly.

Diagnosis

Vascular depression is typically diagnosed using either magnetic resonance imaging (MRI) or clinically defined criteria. MRI-defined vascular depression is more commonly referred to as subcortical ischemic depression (SID) and emphasizes the relationship between MRI identification of lesions in the brain and depressive symptoms. An alternative definition is depression executive dysfunction (DED) syndrome and focuses on the link between clinical symptoms of cardiovascular risk and depressive symptoms. Both of these competing definitions are supported in the literature and provide a strategy to diagnose vascular depression.[ medical citation needed ]

The criteria for MRI-defined vascular depression focus on the presence and severity of either deep white matter lesions, often referred to as white matter hyperintensities, or subcortical grey matter lesions. The most severe lesion in an individual is scored based on predefined criteria and considered in combination with two measures of depressive symptomology.[ medical citation needed ] These white matter lesions are thought to disrupt emotional and cognitive functioning. [1]

Alternatively, clinically defined criteria as proposed initially by Alexopoulos and colleagues (1997) includes dimensions of depressive symptoms, disability, and cognitive impairment. [2] [3] Specifically, DED syndrome has been characterized by a loss of interest in activities, psychomotor retardation, paranoia, and cognitive impairment in the domains of language fluency and visual naming. [4]

Aizenstein and colleagues (2016) proposed diagnostic criteria for vascular depression that incorporate elements of both clinical and MRI-definitions. [1] These diagnostic criteria are:

  1. Evidence of vascular pathology in elderly subjects with or without cognitive impairment
  2. Absence of previous depressive episodes preceding obvious cerebrovascular disease
  3. Presence of cerebrovascular risk factors
  4. Co-incidence of depression with cerebrovascular risk factors
  5. Clinical symptoms characteristic of vascular depression such as executive dysfunction, decrease in processing speed, and lethargy
  6. Neuroimaging data confirming cerebrovascular disease

Studies have not yet been conducted using this set of criteria, so it is unclear whether it provides an advantage over current standards. Some aspects of the criteria are not always necessary to diagnose individuals. For example, one study found that late-onset depression, executive dysfunction, and subcortical gray lesions in individuals were useful for identifying vascular depression, but only the presence of deep white matter lesions was necessary to classify individuals as having the disorder.[ medical citation needed ]

Distinction from Major Depressive Disorder

There is inadequate evidence to support vascular depression as a distinct subtype of major depressive disorder due to mixed results. [3] Specifically, it is difficult to differentiate a diagnosis of vascular depression from similar diagnoses, such as post-stroke or late-life depression. [5] Some researchers suggest that vascular depression may be too restricted in its definition and proposed etiology. [3]

However, there is some evidence of internal validity of vascular depression which provides initial support for its classification as a unique subtype.[ medical citation needed ] The most distinctive symptoms of vascular depression compared to non-vascular depression include increased cognitive and executive impairment, proposed to be associated with cerebrovascular risk factors. [6] [1] [7] Additionally, studies have reported that when compared to individuals with non-vascular depression, those diagnosed with vascular depression tend to be older, have a lower family history of mental illness, and have a history of hypertension. [1] Individuals with vascular depression also tend to have more deficits in self-initiation and concentration, higher cardiac illness burden and cerebrovascular risk factors, cognitive impairment (as associated with the severity of white matter lesions in the brain), and increased treatment resistance. [1] Those with vascular depression have also reported increased lassitude, which is described as a difficulty getting started in the morning and may be related to fatigue.[ medical citation needed ]

An additional study found that individuals with vascular depression reported greater executive dysfunction and apathy compared to both nondepressed individuals with vascular disease and healthy control participants. [8] This provides support that these symptoms may be a result of vascular depression specifically and not solely individuals’ vascular disease.

Cause

Proposed mechanism of vascular depression adapted from Aizenstein et al., 2016 Vascular depression proposed mechanism.png
Proposed mechanism of vascular depression adapted from Aizenstein et al., 2016

Researchers hypothesize that vascular depression disrupts processes in certain parts of the brain to put individuals at risk for developing depression. Two primary mechanisms have been proposed: one associates white matter lesions (attributed to cardiovascular burden) and cerebrovascular risk factors. [9] [10] These two mechanisms parallel the differences between MRI and clinically defined vascular depression, yet do not necessarily represent contradictory mechanisms. These brain changes are thought to be reflected in the white matter lesions identified by MRI. Cerebrovascular risk factors for vascular depression include high blood pressure, diabetes mellitus, hyperlipidemia, coronary heart disease, and tobacco smoking. [11] However, these factors do not account for all cerebrovascular changes in individuals as genetics may play a large role as well.[ medical citation needed ]

Research has found that white matter lesions are particularly important in predicting future depression. Increasing severity, or magnitude, of these lesions predicts an increase in depression over time (as studied in individuals who were already depressed). [3] Additionally, lesions classified as ‘severe’ demonstrate the strongest association with depression. [3] These white matter lesions also predict future depression risk in individuals that are not currently depressed: non-depressed participants with identified white matter lesions were eight times more likely to develop depression within the next three years compared to those without these lesions.[ medical citation needed ] Although the location of these lesions has been studied in connection to late-life depression, [12] more research is needed to determine location's role in the presentation of vascular depression.

Management

Several studies show that the lesions associated with vascular depression are linked to poor depression treatment outcomes. [1] [3] [12] [13] A limitation of these studies is that they lack a measurement of cerebrovascular risk factors before and after the experimental interventions. [5] Therefore, it is unknown if these treatments are targeting these factors specifically or the more general categorization of late-onset geriatric depression.

Keeping this in mind, transcranial magnetic stimulation (TMS), nimodipine, citalopram, and carotid stent placements have been shown to be effective treatments for some individuals with vascular depression. [5] Individuals treated with TMS have reported decreased depressive symptoms. [14] [15] [16] However, in one of these studies the results were based on clinically defined vascular depression. When participants were compared according to MRI defined vascular depression, there was no difference in antidepressant outcomes between those fitting this definition and those not. [14]

Controversy

There are several criticisms regarding the theory of vascular depression. One critique is with regard to the distinction between sufficient and necessary causes for vascular depression. A cause is considered sufficient if its presence is enough to lead to vascular depression, yet it is considered necessary if it is required to develop vascular depression. Some research claims that vascular brain disease is sufficient (but not necessary) for the development of depression, [3] but others have found that ischemic disease may not even be a sufficient causal factor. [13]

A second critique of vascular depression relates to the ambiguity about the causal direction between risk factors and depressive symptoms. It is very difficult to determine if cerebrovascular risk factors cause depressive symptoms or if depressive symptoms instead lead to a worsening of these risk factors, and it may likely be both. [1] White matter lesions, proposed to be a causal risk factor, are common in the elderly and are associated with age. [3] Depression and cerebrovascular risk factors are also common in later life. [3] These factors make it difficult to determine what is the causal factor and to tease apart normal functioning from abnormal in the elderly population.

A final challenge facing the vascular depression hypothesis is its lack of a formal definition. This makes the disorder fundamentally more difficult to study, especially considering that there is still no agreement on diagnostic criteria. Furthermore, some researchers have found that there is no depression symptom profile specific to those with vascular risk factors, [7] calling into question vascular depression's distinction from other depressive disorders.

History

Vascular depression was defined in 1997 by Alexopoulos and colleagues, who theorized that cerebrovascular disease can put individuals at risk for the development or increase of depressive symptoms in older adults. [2] [ non-primary source needed ]

Related Research Articles

<span class="mw-page-title-main">Major depressive disorder</span> Mental disorder involving persistent low mood, low self-esteem, and loss of interest

Major depressive disorder (MDD), also known as clinical depression, is a mental disorder characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities. Introduced by a group of US clinicians in the mid-1970s, the term was adopted by the American Psychiatric Association for this symptom cluster under mood disorders in the 1980 version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), and has become widely used since.

Vascular dementia (VaD) is dementia caused by problems in the blood supply to the brain, resulting from a cerebrovascular disease. Restricted blood supply (ischemia) leads to cell and tissue death in the affected region, known as an infarct. The three types of vascular dementia are subcortical vascular dementia, multi-infarct dementia, and stroke related dementia. Subcortical vascular dementia is brought about by damage to the small blood vessels in the brain. Multi-infarct dementia is brought about by a series of mini-strokes where many regions have been affected. The third type is stroke related where more serious damage may result. Such damage leads to varying levels of cognitive decline. When caused by mini-strokes, the decline in cognition is gradual. When due to a stroke, the cognitive decline can be traced back to the event.

<span class="mw-page-title-main">Binswanger's disease</span> Medical condition

Binswanger's disease, also known as subcortical leukoencephalopathy and subcortical arteriosclerotic encephalopathy, is a form of small-vessel vascular dementia caused by damage to the white brain matter. White matter atrophy can be caused by many circumstances including chronic hypertension as well as old age. This disease is characterized by loss of memory and intellectual function and by changes in mood. These changes encompass what are known as executive functions of the brain. It usually presents between 54 and 66 years of age, and the first symptoms are usually mental deterioration or stroke.

<span class="mw-page-title-main">Cerebrovascular disease</span> Condition that affects the arteries that supply the brain

Cerebrovascular disease includes a variety of medical conditions that affect the blood vessels of the brain and the cerebral circulation. Arteries supplying oxygen and nutrients to the brain are often damaged or deformed in these disorders. The most common presentation of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a hemorrhagic stroke. Hypertension is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis. Atherosclerosis narrows blood vessels in the brain, resulting in decreased cerebral perfusion. Other risk factors that contribute to stroke include smoking and diabetes. Narrowed cerebral arteries can lead to ischemic stroke, but continually elevated blood pressure can also cause tearing of vessels, leading to a hemorrhagic stroke.

In neurology, abulia, or aboulia, refers to a lack of will or initiative and can be seen as a disorder of diminished motivation (DDM). Abulia falls in the middle of the spectrum of diminished motivation, with apathy being less extreme and akinetic mutism being more extreme than abulia. The condition was originally considered to be a disorder of the will, and aboulic individuals are unable to act or make decisions independently; and their condition may range in severity from subtle to overwhelming. In the case of akinetic mutism, many patients describe that as soon as they "will" or attempt a movement, a "counter-will" or "resistance" rises up to meet them.

<span class="mw-page-title-main">CADASIL</span> Medical condition

CADASIL or CADASIL syndrome, involving cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, is the most common form of hereditary stroke disorder, and is thought to be caused by mutations of the Notch 3 gene on chromosome 19. The disease belongs to a family of disorders called the leukodystrophies. The most common clinical manifestations are migraine headaches and transient ischemic attacks or strokes, which usually occur between 40 and 50 years of age, although MRI is able to detect signs of the disease years prior to clinical manifestation of disease.

<span class="mw-page-title-main">Perivascular space</span>

A perivascular space, also known as a Virchow–Robin space, is a fluid-filled space surrounding certain blood vessels in several organs, including the brain, potentially having an immunological function, but more broadly a dispersive role for neural and blood-derived messengers. The brain pia mater is reflected from the surface of the brain onto the surface of blood vessels in the subarachnoid space. In the brain, perivascular cuffs are regions of leukocyte aggregation in the perivascular spaces, usually found in patients with viral encephalitis.

<span class="mw-page-title-main">Psychotic depression</span> Medical condition

Psychotic depression, also known as depressive psychosis, is a major depressive episode that is accompanied by psychotic symptoms. It can occur in the context of bipolar disorder or major depressive disorder. It can be difficult to distinguish from schizoaffective disorder, a diagnosis that requires the presence of psychotic symptoms for at least two weeks without any mood symptoms present. Unipolar psychotic depression requires that psychotic symptoms occur during severe depressive episodes, although residual psychotic symptoms may also be present in between episodes. Diagnosis using the DSM-5 involves meeting the criteria for a major depressive episode, along with the criteria for "mood-congruent or mood-incongruent psychotic features" specifier.

<span class="mw-page-title-main">Transient global amnesia</span> Temporary disruption of short-term memory

Transient global amnesia (TGA) is a neurological disorder whose key defining characteristic is a temporary but almost total disruption of short-term memory with a range of problems accessing older memories. A person in a state of TGA exhibits no other signs of impaired cognitive functioning but recalls only the last few moments of consciousness, as well as possibly a few deeply encoded facts of the individual's past, such as their childhood, family, or home perhaps.

Psychoorganic syndrome (POS), also known as organic psychosyndrome, is a progressive disease comparable to presenile dementia. It consists of psychopathological complex of symptoms that are caused by organic brain disorders that involve a reduction in memory and intellect. Psychoorganic syndrome is often accompanied by asthenia.

Treatment-resistant depression is a term used in psychiatry to describe people with major depressive disorder (MDD) who do not respond adequately to a course of appropriate antidepressant medication within a certain time. Definitions of treatment-resistant depression vary, and they do not include a resistance to psychological therapies. Inadequate response has most commonly been defined as less than 50% reduction in depressive symptoms following treatment with at least one antidepressant medication, although definitions vary widely. Some factors that contribute to inadequate treatment are: a history of repeated or severe adverse childhood experiences, early discontinuation of treatment, insufficient dosage of medication, patient noncompliance, misdiagnosis, cognitive impairment, low income and other socio-economic variables, and concurrent medical conditions, including comorbid psychiatric disorders. Cases of treatment-resistant depression may also be referred to by which medications people with treatment-resistant depression are resistant to. In treatment-resistant depression adding further treatments such as psychotherapy, lithium, or aripiprazole is weakly supported as of 2019.

Psychiatric epidemiology is a field which studies the causes (etiology) of mental disorders in society, as well as conceptualization and prevalence of mental illness. It is a subfield of the more general epidemiology. It has roots in sociological studies of the early 20th century. However, while sociological exposures are still widely studied in psychiatric epidemiology, the field has since expanded to the study of a wide area of environmental risk factors, such as major life events, as well as genetic exposures. Increasingly neuroscientific techniques like MRI are used to explore the mechanisms behind how exposures to risk factors may impact psychological problems and explore the neuroanatomical substrate underlying psychiatric disorders.

<span class="mw-page-title-main">Leukoaraiosis</span> Type of white matter abnormality near the lateral ventricles

Leukoaraiosis is a particular abnormal change in appearance of white matter near the lateral ventricles. It is often seen in aged individuals, but sometimes in young adults. On MRI, leukoaraiosis changes appear as white matter hyperintensities (WMHs) in T2 FLAIR images. On CT scans, leukoaraiosis appears as hypodense periventricular white-matter lesions.

Endogenous depression(melancholia) is an atypical sub-class of major depressive disorder. It could be caused by genetic and biological factors. Endogenous depression occurs due to the presence of an internal stressor instead of an external stressor. Endogenous depression includes patients with treatment-resistant, non-psychotic, major depressive disorder, characterized by abnormal behavior of the endogenous opioid system but not the monoaminergic system. Symptoms vary in severity, type, and frequency and can be attributed to cognitive, social, biological, or environmental factors that result in persistent feelings of sadness and distress. Since symptoms are due to a biological phenomenon, prevalence rates tend to be higher in older adults. Due to this fact, biological-focused treatment plans are often used in therapy to ensure the best prognosis.

<span class="mw-page-title-main">Hyperintensity</span> High intensity on MRI brain scans

A hyperintensity or T2 hyperintensity is an area of high intensity on types of magnetic resonance imaging (MRI) scans of the brain of a human or of another mammal that reflect lesions produced largely by demyelination and axonal loss. These small regions of high intensity are observed on T2 weighted MRI images within cerebral white matter or subcortical gray matter. The volume and frequency is strongly associated with increasing age. They are also seen in a number of neurological disorders and psychiatric illnesses. For example, deep white matter hyperintensities are 2.5 to 3 times more likely to occur in bipolar disorder and major depressive disorder than control subjects. WMH volume, calculated as a potential diagnostic measure, has been shown to correlate to certain cognitive factors. Hyperintensities appear as "bright signals" on an MRI image and the term "bright signal" is occasionally used as a synonym for a hyperintensity.

Mixed anxiety–depressive disorder (MADD) is a diagnostic category defining patients who have both anxiety and depressive symptoms of limited and equal intensity accompanied by at least some autonomic features. Autonomic features are involuntary physical symptoms usually caused by an overactive nervous system, such as panic attacks or intestinal distress. The World Health Organization's ICD-10 describes Mixed anxiety and depressive disorder: "...when symptoms of anxiety and depression are both present, but neither is clearly predominant, and neither type of symptom is present to the extent that justifies a diagnosis if considered separately. When both anxiety and depressive symptoms are present and severe enough to justify individual diagnoses, both diagnoses should be recorded and this category should not be used."

Late-life depression refers to depression occurring in older adults and has diverse presentations, including as a recurrence of early-onset depression, a new diagnosis of late-onset depression, and a mood disorder resulting from a separate medical condition, substance use, or medication regimen. Research regarding late-life depression often focuses on late-onset depression, which is defined as a major depressive episode occurring for the first time in an older person.

A silent stroke is a stroke that does not have any outward symptoms associated with stroke, and the patient is typically unaware they have suffered a stroke. Despite not causing identifiable symptoms, a silent stroke still causes damage to the brain and places the patient at increased risk for both transient ischemic attack and major stroke in the future. In a broad study in 1998, more than 11 million people were estimated to have experienced a stroke in the United States. Approximately 770,000 of these strokes were symptomatic and 11 million were first-ever silent MRI infarcts or hemorrhages. Silent strokes typically cause lesions which are detected via the use of neuroimaging such as MRI. The risk of silent stroke increases with age but may also affect younger adults. Women appear to be at increased risk for silent stroke, with hypertension and current cigarette smoking being amongst the predisposing factors.

Schizophrenia is a primary psychotic disorder, whereas, bipolar disorder is a primary mood disorder which can also involve psychosis. Both schizophrenia and bipolar disorder are characterized as critical psychiatric disorders in the Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5). However, because of some similar symptoms, differentiating between the two can sometimes be difficult; indeed, there is an intermediate diagnosis termed schizoaffective disorder.

Heather Clare Whalley is a Scottish scientist. She is a senior research fellow in Neuroimaging at the Centre for Clinical Brain Sciences, University of Edinburgh., and is an affiliate member of the Centre for Genomic and Experimental Medicine at the University of Edinburgh. Her main focus of research is on the mechanisms underlying the development of major psychiatric disorders using the latest genomic and neuroimaging approaches.

References

  1. 1 2 3 4 5 6 7 8 9 Aizenstein, HJ; Baskys, A; et al. (3 November 2016). "Vascular depression consensus report - a critical update". BMC Medicine (Editorial). 14 (1): 161. doi: 10.1186/s12916-016-0720-5 . PMC   5093970 . PMID   27806704.
  2. 1 2 Alexopoulos, GS; Meyers, BS; Young, RC; Campbell, S; Silbersweig, D; Charlson, M (October 1997). "'Vascular depression' hypothesis". Archives of General Psychiatry. 54 (10): 915–22. doi:10.1001/archpsyc.1997.01830220033006. PMID   9337771.
  3. 1 2 3 4 5 6 7 8 9 Baldwin, RC (January 2005). "Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence". International Journal of Geriatric Psychiatry. 20 (1): 1–11. doi:10.1002/gps.1255. PMID   15578670. S2CID   19083813.[ needs update ]
  4. ↑ Alexopoulos, George S.; Kiosses, Dimitris N.; Klimstra, Sibel; Kalayam, Balkrishna; Bruce, Martha L. (January 2002). "Clinical presentation of the "depression-executive dysfunction syndrome" of late life". The American Journal of Geriatric Psychiatry. 10 (1): 98–106. ISSN   1064-7481. PMID   11790640.
  5. 1 2 3 Brunoni, AR; Benseñor, IM; Alves, TC (December 2011). "Therapeutic interventions for vascular depression: a systematic review". Revista Brasileira de Psiquiatria. 33 (4): 400–9. doi: 10.1590/S1516-44462011000400015 . PMID   22189931. Open Access logo PLoS transparent.svg
  6. ↑ Alexopoulos, G. S., Meyers, B. S., Young, R. C., Kakuma, T., Silbersweig, D., & Charlson, M. (1997). Clinically defined vascular depression. American Journal of Psychiatry, 154(4), 562–565. https://doi.org/10.1176/ajp.154.4.562
  7. 1 2 Naarding, P., Tiemeier, H., Breteler, M. M. B., Schoevers, R. A., Jonker, C., Koudstaal, P. J., & Beekman, A. T. F. (2007). Clinically defined vascular depression in the general population. Psychological Medicine, 37(3), 383–392. https://doi.org/10.1017/S0033291706009196
  8. ↑ Bella, R., Ferri, R., Cantone, M., Pennisi, M., Lanza, G., Malaguarnera, G., … Pennisi, G. (2011). Motor cortex excitability in vascular depression. International Journal of Psychophysiology, 82(3), 248–253.
  9. ↑ Dufouil, C.; de Kersaint-Gilly, A.; Besançon, V.; Levy, C.; Auffray, E.; Brunnereau, L.; Alpérovitch, A.; Tzourio, C. (2001-04-10). "Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort". Neurology. 56 (7): 921–926. doi:10.1212/wnl.56.7.921. ISSN   0028-3878. PMID   11294930. S2CID   25407657.
  10. ↑ Krishnan, K. Ranga Rama; Taylor, Warren D.; McQuoid, Douglas R.; MacFall, James R.; Payne, Martha E.; Provenzale, James M.; Steffens, David C. (2004-02-15). "Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression". Biological Psychiatry. 55 (4): 390–397. doi:10.1016/j.biopsych.2003.08.014. ISSN   0006-3223. PMID   14960292. S2CID   29802787.
  11. ↑ Armstrong, Nicole M.; Meoni, Lucy A.; Carlson, Michelle C.; Xue, Qian-Li; Bandeen-Roche, Karen; Gallo, Joseph J.; Gross, Alden L. (May 2017). "Cardiovascular risk factors and risk of incident depression throughout adulthood among men: The Johns Hopkins Precursors Study". Journal of Affective Disorders. 214: 60–66. doi:10.1016/j.jad.2017.03.004. ISSN   1573-2517. PMC   5405441 . PMID   28284097.
  12. 1 2 Simpson, S., Baldwin, R. C., Jackson, A., & Burns, A. S. (1998). Is subcortical disease associated with a poor response to antidepressants ? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychological Medicine, 28, 1015–1026.
  13. 1 2 Taylor, W. D., Steffens, D. C., & Krishnan, K. R. (2006). Psychiatric Disease in the Twenty-First Century: The Case for Subcortical Ischemic Depression. Biological Psychiatry, 60(12), 1299–1303. https://doi.org/10.1016/j.biopsych.2006.05.028
  14. 1 2 Jorge, R. E., Moser, D. J., Acion, L., & Robinson, R. G. (2008). Treatment of Vascular Depression Using Repetitive Transcranial Magnetic Stimulation 3. Archives of General Psychiatry, 65(3), 268–276. https://doi.org/10.1001/archgenpsychiatry.2007.45
  15. ↑ Narushima, K., McCormick, L. M., Yamada, T., Thatcher, R. W., & Robinson, R. G. (2010). Subgenual Cingulate Theta Activity Predicts Treatment Response of Repetitive Transcranial Magnetic Stimulation in Participants With Vascular Depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(1), 75–84. https://doi.org/10.1176/jnp.2010.22.1.75
  16. ↑ Fabre, I., Galinowski, A., Oppenheim, C., Gallarda, T., Meder, J. F., de Montigny, C., … Poirier, M. F. (2004). Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: An open trial. International Journal of Geriatric Psychiatry, 19(9), 833–842. https://doi.org/10.1002/gps.1172
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.